Millennium Management
CLVS

Millennium Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Millennium Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-25,000
Closed -$2.34M – 3987
2017
Q2 		$2.34M Buy
+25,000
New +$1.53M ﹤0.01% 1985
2016
Q3 		– Sell
-75,000
Closed -$1.03M – 3715
2016
Q2 		$1.03M Buy
+75,000
New +$1.1M ﹤0.01% 2149
2014
Q4 		– Sell
-75,000
Closed -$3.4M – 4369
2014
Q3 		$3.4M Buy
+75,000
New +$3.13M 0.01% 1518

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management's CLVS Position: Q4 2022 in Review

Millennium Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 976,384 shares — an estimated $1.16M sold.

Millennium Management first reported a position in CLVS in Q2 2013 and held it in 33 quarters. The position peaked at $47.8M in Q4 2016. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Millennium Management reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Millennium Management sold 976,384 Clovis Oncology, Inc. shares in Q4 2022, an estimated $1.16M.
  • Millennium Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 33 quarters.
  • Millennium Management's Clovis Oncology, Inc. position peaked at $47.8M in Q4 2016.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.